Customize your experience
You decide what information you want to see on your Sanofi Campus
More about science
Choose a therapeutic area to find related scientific content
Cardiovascular
Diabetes
Atopic Dermatitis
Asthma
Nasal Polyps
Rare Diseases
Vaccines
Multiple Sclerosis
Latest trends
Explore the most popular scientific articles and videos among Campus Sanofi users
Events
Stay up to date and register for the latest events and view webinar recordings
.png)
Support for your patients
Discover the selection of support materials for patients from different therapeutic areas
Our Products
Zympass®
Combination of Rosuvastatin Calcium & Ezetimibe used as adjunct to diet for treatment of Primary Hypercholesterolemia or Homozygous Familial Hypercholesterolemia.
Toujeo®
Insulin Glargine 300, a long-acting insulin administered subcutaneously and used to treat diabetes mellitus in adults, adolescents and children from the age of 6 years.
Clexane®
Enoxaparin Sodium is a low molecular weight heparin (LMWH) that is administered subcutaneously and used as antithrombotic agent.
Praluent®
Alirocumab is a fully human IgG1
monoclonal antibody. It’s a PCSK9 inhibitor
that is administered subcutaneously.
Plavix®
Clopidogrel is an inhibitor of platelet
aggregation administered orally and
indicated for Secondary prevention of
atherothrombotic events.
Soliqua®
Combination of Insulin Glargine (a basal insulin analog) & Lixisenatide (a GLP-1 receptor agonist) administered subcutaneously.
Dupixent®
Is a fully human monoclonal antibody with
multiple indications in different therapeutic
areas.
Lantus®
Insulin Glargine 100, a long-acting insulin administered subcutaneously and used to treat diabetes mellitus in adults, adolescents and children from the age of 2 years.
Aubagio®
AUBAGIO® is a once-daily oral tablet that is indicated for adult patients with relapsing remitting multiple sclerosis (RRMS)
Lemtrada®
Lemtrada® is a monoclonal antibody produced in mammalian cells (Chinese Hamster Ovary).
Depakine®
Amaryl®
Glimepiride is an orally active hypoglycaemic substance belonging to the sulfonylurea group. It may be used in non-insulin dependent diabetes mellitus.
▼This drug is subject to additional monitoring, the reporting of suspected adverse reactions associated with this drug is a priority.
YOU WILL NOW BE LEAVING THE SITE
By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.